tiprankstipranks
Cogent Biosciences (COGT)
NASDAQ:COGT
US Market

Cogent Biosciences (COGT) Balance Sheet

513 Followers

Cogent Biosciences Balance Sheet

Cogent Biosciences's total assets for Q3 2023 were $355.45M, a decrease of -9.41% from the previous quarter. COGT total liabilities were $52.55M for the fiscal quarter, a 19.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 300.81M$ 232.09M$ 250.92M$ 49.42M$ 85.93M
Total Liabilities
$ 45.08M$ 17.91M$ 16.25M$ 17.66M$ 25.69M
Total Equity Gross Minority
$ 255.74M$ 214.18M$ 234.67M$ 31.76M$ 60.23M
Total Capitalization
$ 255.74M$ 214.18M$ 234.67M$ 31.76M$ 60.23M
Preferred Stock Equity
--$ 110.88M--
Capital Lease Obligations
--$ 5.21M$ 6.03M$ 0.00
Currency in USD

Cogent Biosciences Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis